Page 2 - Les Meilleurs Cancer des amygdales pour le traitement de cancer des amygdales à Istanbul - TOP-30 des médecins

Spécialisé dans le traitement du cancer des amygdales avec une formation approfondie en oncologie médicale à l'Université de Kocaeli.

• Formé à la Faculté de Médecine Cerrahpaşa de l'Université d'Istanbul
• Plus de 20 ans d'expérience en médecine interne et en oncologie
• Travail au sein de plusieurs hôpitaux pour acquérir une vaste expérience clinique

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Le professeur Nail Paksoy est spécialisé dans le traitement du cancer des amygdales en tant que professeur associé à l'hôpital Medipol Bahçelievler, avec une vaste expérience en oncologie médicale.

• Certifié par l'ESMO en oncologie médicale
• Impliqué dans 8 essais cliniques internationaux sur les traitements du cancer
• Publication de nombreuses études dans des revues d'oncologie renommées

Le Dr Karatas est spécialisé en chirurgie de la tête et du cou, avec une vaste formation internationale acquise en Europe et aux États-Unis.

• Formé dans des institutions prestigieuses telles que la faculté de médecine de Hanovre et l'université d'État de l'Ohio
• Membre de plusieurs sociétés professionnelles, dont l'American Academy of Otolaryngology
• Expertise dans les techniques chirurgicales avancées pour les pathologies de la tête et du cou

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le Dr Sahibov est spécialisé en radio-oncologie, formé à l'Université de Marmara, et se concentre sur les traitements précis du cancer.

• Formation à la Faculté de Médecine de l'Université de Marmara
• Spécialisation en radio-oncologie de 2012 à 2016
• Maîtrise de l'anglais, facilitant une communication claire avec les patients